Press release
Pleural Diseases Market to Expand Significantly by 2032, States DelveInsight Report | Lung Therapeutics, Angiotech Pharmaceuticals, Clover Biopharma
DelveInsight's "Pleural Diseases Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Pleural Diseases, historical and forecasted epidemiology as well as the Pleural Diseases market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Pleural Diseases market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pleural Diseases Market Forecast [https://www.delveinsight.com/sample-request/pleural-diseases-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Pleural Diseases Market Report:
*
The Pleural Diseases market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
*
The FDA granted approval for the use of Skytrofa (lonapegsomatropin) in September 2021 for the treatment of pediatric patients aged one year and older who weigh at least 11.5 kg and have growth failure as a result of insufficient endogenous growth hormone secretion
*
The study by Rogol stated that GHD in children is a relatively rare condition. In the United States, it was estimated to occur in approximately 1 in 3500 to 4000 children
*
As per National Institute for Health and Clinical Excellence (NICE), the prevalence of growth hormone deficiency was estimated to be between 1 in 3500 and 1 in 4000 children
*
In about half of the children with growth hormone deficiency (50%), the cause is unknown (idiopathic growth hormone deficiency)
*
Key Pleural Diseases Companies: Istituto Oncologico Veneto, RS Oncology, PrECOG, LLC, AstraZeneca, Oncotelic Inc., Trizell Ltd, MedImmune LLC, Sanofi, and others
*
Key Pleural Diseases Therapies: Carboplatin, RSO-021, Durvalumab, Volrustomig, OT-101, rAd-IFN, Tremelimumab, THOR-707, and others.
*
The Pleural Diseases market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Pleural Diseases pipeline products will significantly revolutionize the Pleural Diseases market dynamics.
Pleural Diseases Overview:
Pleural diseases refer to medical conditions that affect the pleura, the thin membrane surrounding the lungs and lining the chest cavity. Common pleural diseases include pleurisy (inflammation of the pleura), pleural effusion (excess fluid in the pleural space), pneumothorax (collapsed lung), and pleural thickening. These conditions can result from infections, injuries, cancers, or autoimmune disorders and often cause symptoms like chest pain, shortness of breath, and coughing. Diagnosis and treatment depend on the underlying cause and severity of the condition.
Get a Free sample for the Pleural Diseases Market Report:
https://www.delveinsight.com/report-store/pleural-diseases-market [https://www.delveinsight.com/report-store/pleural-diseases-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Pleural Diseases Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Pleural Diseases Epidemiology Segmentation:
The Pleural Diseases market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
*
Total Prevalence of Pleural Diseases
*
Prevalent Cases of Pleural Diseases by severity
*
Gender-specific Prevalence of Pleural Diseases
*
Diagnosed Cases of Episodic and Chronic Pleural Diseases
Download the report to understand which factors are driving Pleural Diseases epidemiology trends @ Pleural Diseases Epidemiology Forecast [https://www.delveinsight.com/sample-request/pleural-diseases-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Pleural Diseases Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Pleural Diseases market or expected to get launched during the study period. The analysis covers Pleural Diseases market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Pleural Diseases Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Pleural Diseases Therapies and Key Companies
*
Carboplatin: Istituto Oncologico Veneto
*
RSO-021: RS Oncology
*
Durvalumab: PrECOG, LLC.
*
Volrustomig: AstraZeneca
*
OT-101: Oncotelic Inc.
*
rAd-IFN: Trizell Ltd
*
Tremelimumab: MedImmune LLC
*
THOR-707: Sanofi
Discover more about therapies set to grab major Pleural Diseases market share @ Pleural Diseases Treatment Market [https://www.delveinsight.com/sample-request/pleural-diseases-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Scope of the Pleural Diseases Market Report
*
Study Period: 2019-2032
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Pleural Diseases Companies: Istituto Oncologico Veneto, RS Oncology, PrECOG, LLC, AstraZeneca, Oncotelic Inc., Trizell Ltd, MedImmune LLC, Sanofi, and others
*
Key Pleural Diseases Therapies: Carboplatin, RSO-021, Durvalumab, Volrustomig, OT-101, rAd-IFN, Tremelimumab, THOR-707, and others
*
Pleural Diseases Therapeutic Assessment: Pleural Diseases current marketed and Pleural Diseases emerging therapies
*
Pleural Diseases Market Dynamics: Pleural Diseases market drivers and Pleural Diseases market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Pleural Diseases Unmet Needs, KOL's views, Analyst's views, Pleural Diseases Market Access and Reimbursement
To know more about Pleural Diseases companies working in the treatment market, visit @ Pleural Diseases Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/pleural-diseases-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Pleural Diseases Market Report Introduction
2. Executive Summary for Pleural Diseases
3. SWOT analysis of Pleural Diseases
4. Pleural Diseases Patient Share (%) Overview at a Glance
5. Pleural Diseases Market Overview at a Glance
6. Pleural Diseases Disease Background and Overview
7. Pleural Diseases Epidemiology and Patient Population
8. Country-Specific Patient Population of Pleural Diseases
9. Pleural Diseases Current Treatment and Medical Practices
10. Pleural Diseases Unmet Needs
11. Pleural Diseases Emerging Therapies
12. Pleural Diseases Market Outlook
13. Country-Wise Pleural Diseases Market Analysis (2019-2032)
14. Pleural Diseases Market Access and Reimbursement of Therapies
15. Pleural Diseases Market drivers
16. Pleural Diseases Market barriers
17. Pleural Diseases Appendix
18. Pleural Diseases Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=pleural-diseases-market-to-expand-significantly-by-2032-states-delveinsight-report-lung-therapeutics-angiotech-pharmaceuticals-clover-biopharma]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pleural Diseases Market to Expand Significantly by 2032, States DelveInsight Report | Lung Therapeutics, Angiotech Pharmaceuticals, Clover Biopharma here
News-ID: 3967790 • Views: …
More Releases from ABNewswire
Is Couples Therapy Right? Signs It's Time to See a Counsellor in Birmingham
Relationships can be both fulfilling and challenging. No matter how strong a couple may seem on the outside, it's natural to face hurdles along the way. Miscommunication, stress, life changes, or unresolved issues can create distance between partners. While every couple goes through ups and downs, knowing when to seek professional support can make all the difference. If you've ever found yourself searching for "couples therapy near me" or wondering…
Rialto-Based Get it from Bo Pioneers Collaborative E-Commerce Model Supporting M …
Get it from Bo revolutionizes online retail through strategic manufacturer partnerships that deliver quality products at reasonable prices. The California-based platform, established in 2024, creates sustainable business relationships while expanding inventory daily to serve diverse consumer needs.
Get it from Bo is establishing new standards in the e-commerce industry through its innovative collaborative approach that prioritizes sustainable partnerships with manufacturers and brands while delivering exceptional value to consumers. The Rialto, California-based…
Daily Vibe Launches Comprehensive Fitness Products Store for Diverse Consumer Ma …
New fitness retailer Daily Vibe enters the market with targeted product selections designed to support active lifestyles across multiple demographics. The startup focuses on serving fitness enthusiasts, health-conscious consumers, and older adults seeking quality fitness products.
Founded by Ja'von L. Watson and Joyleena S. Watson, AGAIT International is a fast-growing Atlanta-based tech company dedicated to solving social and economic challenges through creative business and digital solutions. The company develops and manages…
Prolift Handling Brings Advanced pewag Lifting Technology to Ireland
Prolift Handling launches pewag levo Balancer and levo Compensator in Ireland - two advanced lifting solutions that improve safety and precision in heavy lifting operations through remote-controlled positioning and automatic load balancing.
Dublin, Ireland - Sep 30, 2025 - Prolift Handling, Ireland's exclusive pewag partner, today launched two advanced lifting solutions designed to tackle the industry's most challenging safety and precision requirements: the pewag levo Balancer and pewag levo Compensator.
The pewag…
More Releases for Pleural
Pleural Effusion Market Emerging Trends and Growth Prospects 2034
Introduction
Pleural effusion, a condition characterized by the accumulation of excess fluid in the pleural cavity, often results from underlying diseases such as malignant tumors, heart failure, and infections. This condition can significantly impair respiratory function and lead to symptoms like shortness of breath, chest pain, and coughing. The global burden of pleural effusion is rising, particularly due to the increasing prevalence of lung cancer, heart disease, and chronic respiratory diseases.
The…
Malignant Pleural Effusion Pipeline Therapeutics Assessment Report 2024 (Updated …
DelveInsight's, "Malignant Pleural Effusion Pipeline Insight 2024" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Malignant Pleural Effusion pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Malignant Pleural Effusion Research.…
Pleural Drainage Catheters Market Size 2024 to 2031.
Market Overview and Report Coverage
A Pleural Drainage Catheter is a medical device used to drain fluid or air from the pleural cavity surrounding the lungs. These catheters are commonly used in patients suffering from conditions such as pneumonia, lung cancer, or pleural effusion.
The Pleural Drainage Catheters Market is expected to witness significant growth in the coming years, with a projected CAGR of 7.80% during the forecasted period. This…
Pleural Drainage Catheters Market Will Generate Record Revenue by 2031
Pleural Drainage Catheters Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 14.88% from 2024 to 2030. The Pleural Drainage Catheters Market is witnessing a significant surge, driven by a myriad of factors including the rising prevalence of respiratory disorders, advancements in catheter technology, and increasing demand for minimally invasive treatment options. This article explores the latest…
Global Pleural Effusion Drug Market - Industry Trends and Forecast to 2028
Global Pleural Effusion Drug Market - Industry Trends and Forecast to 2028
The pleural effusion drug market is expected to gain market growth at a potential rate of 4.70% in the forecast period of 2021 to 2028. Increase in prevalence rate of pleural effusion worldwide is the vital factor escalating the pleural effusion drug market growth.
Pleural effusion is a type of condition in which excessive fluids build-up or accumulates in the…
Malignant Pleural Effusions to Gain Maximum Traction in Pleural Catheters Market …
250 Pages Pleural Catheters Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider
According to Fact MR’s recent market research, sales of Pleural Catheters to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.
Focus on…
